REGENXBIO is a gene therapy biotechnology company based in Maryland. It lobbied on health issues, including the Food and Drug Administration's accelerated approval pathway for rare diseases. Filings show one disclosure with no reported spending and that it used the lobbying firm THEGROUP DC, LLC.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DAVID CLEARY
The latest disclosures for this client.
THEGROUP DC, LLC
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
THEGROUP DC, LLC